药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
Naloxegol
The serum concentration of Naloxegol can be increased when it is combined with Ponatinib.
Glucosamine
Ledipasvir
The serum concentration of Ledipasvir can be increased when it is combined with Ponatinib.
Glucosamine
Edoxaban
The serum concentration of Edoxaban can be increased when it is combined with Ponatinib.
Glucosamine
Armodafinil
The metabolism of Ponatinib can be increased when combined with Armodafinil.
Glucosamine
Afatinib
The serum concentration of Afatinib can be increased when it is combined with Ponatinib.
Glucosamine
Methoxy polyethylene glycol-epoetin beta
The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Ponatinib.
Glucosamine
Peginesatide
The risk or severity of Thrombosis can be increased when Peginesatide is combined with Ponatinib.
Glucosamine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Ponatinib.
Glucosamine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Ponatinib.
Glucosamine
Idelalisib
The risk or severity of adverse effects can be increased when Ponatinib is combined with Idelalisib.
Glucosamine
Siponimod
The risk or severity of adverse effects can be increased when Ponatinib is combined with Siponimod.
Glucosamine
Bleselumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Bleselumab.
Glucosamine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Rozanolixizumab.
Glucosamine
Risankizumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Risankizumab.
Glucosamine
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Ponatinib is combined with Monomethyl fumarate.
Glucosamine
Tetrandrine
The risk or severity of adverse effects can be increased when Ponatinib is combined with Tetrandrine.
Glucosamine
Fluclorolone
The risk or severity of adverse effects can be increased when Ponatinib is combined with Fluclorolone.
Glucosamine
Fluperolone
The risk or severity of adverse effects can be increased when Ponatinib is combined with Fluperolone.
Glucosamine
Begelomab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Begelomab.
Glucosamine
Fluocortin
The risk or severity of adverse effects can be increased when Ponatinib is combined with Fluocortin.